Australia’s My Health Record has come under considerable criticism during a launch period that has been marred by a row over privacy – but a group representing ethnic communities has backed
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh